welcome
Reuters

Reuters

Health

Health

China's health regulator defends quality of local generic drugs

Reuters
Summary
Nutrition label

81% Informative

China 's healthcare regulator defends efficacy of off-patent medicines approved to be distributed through public hospitals.

Investigation into quality concerns had found them to be unsubstantiated, says regulator.

China rolled out bulk-buy programme in 2018 in an attempt to negotiate lower prices from drug manufacturers.

VR Score

91

Informative language

98

Neutral language

60

Article tone

formal

Language

English

Language complexity

71

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links